{"id":226664,"date":"2026-09-02T10:06:38","date_gmt":"2026-09-02T04:36:38","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=226664"},"modified":"2026-09-02T10:06:39","modified_gmt":"2026-09-02T04:36:39","slug":"abbott-india-share-bull-case-vs-bear-case-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/abbott-india-share-bull-case-vs-bear-case-2026\/","title":{"rendered":"Abbott India Share: Bull Case vs Bear Case for 2026"},"content":{"rendered":"
<\/div>\n

Abbott India CMP Rs 26,140 on 1 Sep 2026. 52W High Rs 32,775, Low Rs 25,150. PE 34.03 vs sector 51.43. RSI 22.77.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Abbott India bull case for 2026 points toward the stock retesting its 52 week high of Rs 32,775, built on the strengths discussed below. The Abbott India bear case points toward a slide back near its 52 week low of Rs 25,150 if the risks play out instead. The stock currently trades at Rs 26,140, with a price to earnings multiple of 34.03 against an industry average of 51.43. The next two quarters of earnings and sector data will likely decide which case plays out.<\/p>\n<\/div>\n

The Abbott India bull case is under the spotlight as investors weigh Abbott India’s recent price action against its underlying fundamentals. The stock trades at Rs 26,140, against a 52 week high of Rs 32,775 and a 52 week low of Rs 25,150, leaving room for both the Abbott India bull case and the Abbott India bear case to find support in the data.<\/p>\n

Abbott India operates in the Pharmaceuticals space, and its return on equity of 32.51 percent and debt to equity ratio of 0.04 form the backbone of the fundamental picture. This article lays out the full Abbott India bull case and bear case, the data behind each scenario, and the catalysts that could tip the balance one way or the other.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n